Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation

Dyslipidemia is one of the complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT), and it is often underestimated and undertreated. Dyslipidemia in allo-HSCT recipients has been confirmed to be associated with endocrine dysfunction, acute and chronic graft-versus-host dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yingxue, Ma, Xiaojing, Pan, Jie, Ma, Rongqiang, Jiang, Yujie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344644/
https://www.ncbi.nlm.nih.gov/pubmed/35918766
http://dx.doi.org/10.1186/s12944-022-01665-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344644/
https://www.ncbi.nlm.nih.gov/pubmed/35918766
http://dx.doi.org/10.1186/s12944-022-01665-3

Ejemplares similares